Hepatology (Baltimore, Md.) 2018 Apr
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.
Related Questions
New answer by at University of Texas Southwestern Medical School (August 15, 2024)
I agree with the below; it is not typically recommended to switch to Cabenuva (cabotegravir + rilpivirine) in patients with active HBV infection (positive HBsAg), as it does n...